The drug has already been granted priority review, positioning it for a potential regulatory decision by mid 2026
I do not take a GLP-1 myself but have worked with hundreds of people who have
Typical side effects include: Mild to moderate nausea, especially after larger or heavy meals A feeling of fullness or heavy stomach even after smaller meals Burping or changes in how your stomach feels after eating Constipation or, in some people, softer or more frequent stools Simple adjustments can often make these easier to handle: Eat more slowly and stop as soon as you feel comfortably full Choose lighter, less greasy meals on days when symptoms are stronger Drink water regularly throughout the day rather than in one large amount Go for gentle walks to help support digestion For many people, side effects decrease as their body adjusts and the dose increases gradually
1 Systemic, neuromodulatory, and hepatic effects of GLP-1RA
The Tirzepatide segment is expected to grow at a CAGR of 12.87% during the forecast period due to its dual GIP/GLP-1 receptor mechanism, superior weight-loss efficacy demonstrated in comparative clinical studies, and expanding regulatory approvals across metabolic disease indications
Lilly also has broader ambitions for orforglipron beyond obesity
